FUNDED RESEARCH FOR 2022-2023

George C. Cotzias Fellowship

The George C. Cotzias Fellowship is named in honor of the scientist who had a critical role in developing Levodopa as a treatment for Parkinson’s disease and is awarded with the purpose of encouraging young neurologists to follow in his footsteps.


Gary Ho, MD, PhD

Brigham and Women’s Hospital/Harvard Medical School, Boston, MA

Leveraging protein palmitoylation to correct vesicle trafficking defects in Parkinson’s disease

Abby L. Olsen, MD, PhD

University of Pittsburgh, Pittsburgh, PA

Harnessing the untapped therapeutic potential of glia in Parkinson’s disease


Diversity in Parkinson’s Disease Research Grant

The Diversity in Parkinson’s Disease Research Grant is awarded to an investigator studying the health disparities or differences among under-represented PD communities.


Post-Doctoral Fellowships

This fellowship is awarded to support post-doctoral scientists whose research holds promise to provide new insights into the pathophysiology, etiology, and treatment of PD.

Tyler Camp, PhD

University of Illinois Urbana-Champaign, Champaign, IL

α-synuclein oligomerization and membrane localization in Parkinson’s disease

Anastasia, Kuzkina, MD

Brigham and Women’s Hospital/Harvard Medical School, Boston, MA

Developing human iPSC models for examining host-strain interactions in synucleinopathy

Andrew Zimnik, PhD

Columbia University, New York, NY

Role of basal ganglia output in acquiring and executing complex motor skills


Research Grants

This grant is awarded to investigators performing innovative PD research at major academic institutions across the United States.

Ronald Emeson, PhD

Vanderbilt University, Nashville, TN

ADAR-Mediated LRRK2 Therapeutics in Parkinson’s Disease

Sunil Kumar, PhD

University of Denver, Denver, CO

Therapeutic validation of novel targets associated with Parkinson’s disease

Gabsang Lee, PhD

Johns Hopkins University School of Medicine, Baltimore, MD

In vitro and in vivo efficacy of hit compound selected from OASIS drug screening platform

Michael Lodato, PhD

University of Massachusetts Chan Medical School, Worcester, MA

Single-cell whole genome sequencing analysis of DNA damage and somatic mutation in the human Parkinson’s disease brain

Ryan Roemmich, PhD

Hugo W. Moser Research Institute at Kennedy Krieger, Baltimore, MD

An automated mHealth approach for video-based motor assessment in Parkinson’s disease

Martine Tetrault, PhD

Centre Hospitalier de l’Université de Montréal, Montreal, Canada

Regulation of aberrant immunity in Parkinson’s disease by stearoyl-CoA desaturase

Nicolas Tritsch, PhD

New York University Grossman School of Medicine, New York, NY

Revealing how striatal circuits gradually changes as dopamine neurons degenerate

Hisashi Umemori, MD, PhD

Boston Children’s Hospital/Harvard Medical School, Boston, MA

The nigrostriatal-specific dopaminergic synapse organizer and Parkinson’s disease

Laura Volpicelli-Daley, PhD

University of Alabama at Birmingham, Birmingham, AL

mGluR4 activation to rescue amygdala defects caused by aggregated alpha-synuclein

Scott Waldman, MD, PhD

Thomas Jefferson University, Philadelphia, PA

Targeting GUCY2C for Neuroprotection in Experimental Parkinson’s Disease


IN THE NEWS

APDA Awards $2.35 Million in Research Grants. 

Click here to read the Press Release